The International Cancer Genome Consortium PedBrain Tumor Project identified PTPRZ1-MET (ZM) gene fusions in approximately 10% of cases of primary pediatric GBMs [77], whereas another study detected 15% of the ZM fusion gene in secondary GBM cases [78]. Here, MET is linked to neoplasm.